Case Report

Metachronous Pancreatic Metastases of a Bilateral Renal Cell Carcinoma : A Case Report

Soufiane Ennaciri¹*, Toufik Michel Bitard², Fadi Al Derzi², Alban Zarzavadjian Le Bian² and Moulay Hassan Farih¹

¹Department of Urology, Hassan II University Hospital, Morocco

²Department of Visceral and Urological Surgery, Simone Veil Hospital, France

Submission: March 14, 2019; Published: April 10, 2019

*Corresponding author: Soufiane Ennaciri, Department of Urology, Hassan II University Hospital, Fes, Morocco

How to cite this article: Soufiane E, Toufik M B, Fadi A D, Alban Z L B, Moulay HF. Metachronous Pancreatic Metastases of a Bilateral Renal Cell 002 Carcinoma : A Case Report. JOJ Case Stud. 2019; 10(1): 555779. DOI: 10.19080/JOJCS.2019.10.555779.

Abstract

We report the case of a 57-year-old patient who developed two pancreatic metastases eight years after surgical treatment of a bilateral renal cell carcinoma. A subtotal pancreatectomy with splenectomy was performed. Three years later, the patient is in good general condition and free from any tumor recurrence. Pancreatic metastases of kidney cancers are rare and onset usually late. They are most often fortuitous discovery during the surveillance of the neoplastic disease. The curative treatment is most often surgical.

Keywords: Pancreatic metastases; Bilateral renal cell carcinoma; Nephrectomy; Pancreatectomy

Introduction

Adult kidney cancer represents 3% of all cancers and the third urological neoplasm [1]. Metastases of renal cancers are usually located in the lung, liver or bones. Secondary pancreatic localization are unusual [2].

Case Report

A 57 years-old man, with a history of smoking, presented to the emergency room for a lower back pain and hematuria with blood clots.

The uroscan by computed tomography showed a bilateral kidney tumor. The left one was very large measuring 12x8x9cm taking up the lower two-thirds of the kidney. There was also a lymphadenopathy and no left renal vein thrombosis. The right kidney was occupied by an heterogenous polar superior tumor, measuring 4.3x5.1x5cm. Screening for metastasis was normal.

The patient under went at first a left radical nephrectomy. The anatomopathological study revealed a clear cell renal cell carcinoma : Fuhrman grade 3, stage pT2N0. Two weeks later, a right partial nephrectomy was performed and histological analysis found a clear cell renal cell carcinoma : Fuhrman grade 2, stage pT1N0 (Figure 1).

The survey was by CT without injection and MRI as the patient developed renal failure. Two years after nephrectomy, the imaging revealed two suspicious pancreatic nodules, on the body and the tail measuring 3 and 1cm respectively (Figure 2).

Endoscopic ultrasound with biopsy confirmed the metastatic nature of the pancreatic lesions. So the treatment was as à subtotal pancreatectomy with splenectomy. Besides the appearance of diabetes, there was no tumoral recurrence three years after the surgery.

Discussion

Clear cell renal cell carcinoma represents up to 90% of adult kidney cancers. Risk factors include mainly smoking and obesity [3]. The tumor is usually unilateral. In case of bilateral localization, a hereditary disease should be suspected and the surgical approach should be conservative [4] (Figure 3-5).

Pancreatic metastases of renal carcinoma are rare, representing 2 to 5% of pancreatic malignancies [5]. The average time between the nephrectomy and the metastasis diagnosis is 8 years [5] as it was the case for our patient.

Pancreatic metastasis are often asymptomatic. However, they can cause abdominal pain, jaundice, gastrointestinal bleeding, weight loss, exocrin or endocrin pancreatic insuffiency and even acute pancreatitis [5,6].

In most cases, there are discovered incidentally in imaging. Indded, doppler ultrasound and abdominal CT are firstline examination, they allow us to see the heterogenous and hypervascular character of the pancreatic lesion. RMI is of great help in case of renal failure. The result are similar to the CT scan but with better detection of the lesion before injection of contrast product wish is hypoitense on T1 and hyperintense on T2-weighted images [7].

The diagnosis can only be confirmed with the anatomopathological examination [8]. Which can be done after a guided CT, endoscopic ultrasound biopsy or after surgical excision [7].

Surgical excision is currently the best curative treatment. Depending on the lesions topography, a pancreaticoduodenectomy or a spleno-pancreatectomy can be performed [9,10].

Conclusion

Pancreatic metastases of clear cell renal cell carcinoma are rare and can occur many years after the nephrectomy, hence the interest of a careful surveillance. The accessebility of medical imaging leads to the early diagnosis at an asymptomatic stage, thus making them accessible for a surgical treatement, allowing a good survival rate in the long.

References

1. Charles T, Lindner V, Matau A, Roy C, Lang H (2010) Cancer du rein. EMC - Urol 3(4): 1-30.
2. Méjean A, Lebret T (2008) Sites métastatiques atypiques du cancer du rein. Prog En Urol 18: S320-S326.
3. Ljungberg B, Campbell SC, Cho HY, Jacqmin D, Lee JE, et al. (2011) The epidemiology of renal cell carcinoma. Eur Urol 60(4): 615-621.
4. Bensalah K, Albiges L, Bernhard JC, Bigot P, Bodin T, et al. (2016) Recommandations en onco-urologie 2016-2018 du CCAFU : Cancer du rein. Prog En Urol 27(Supplement 1): S27-S51.
5. Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce AA, et al. (2008) Pancreatic metastasis from renal cell carcinoma: which Patients benefit from surgical resection? Ann Surg Oncol 15(4): 1161-1168.
6. Paparel P, Cotton F, Voiglio E, Decaussin M, Isaac S, et al. (2004) Un cas de métastase pancréatique tardive d’un carcinome à cellules claires ré Prog En Urol 3.
7. Roy C, Chaudron V, Benhaim R, Renard C, Bachelier P, et al. (2011) Métastases pancréatiques métachrones des carcinomes rénaux: rôle de l’imagerie à propos de 17 patients avec corrélations chirurgicales. J Radiol 92(12): 1091-1100.
8. Faure JP, Richer JP, Irani J, Bon D, Dugue T, et al. (1998) Cancer du rein et métastases pancréatiques tardives. A propos de 3 cas et revue de la litté Prog En Urol 4.
9. Peschaud F, Cheynel N, Hagry O, Tremeaux J, Rat P, et al. (2002) Traitement chirurgical des métastases pancréatiques des cancers du rein. Ann Chir 127(7): 527-531.
10. Schauer M, Vogelsang H, Siewert JR (2008) Pancreatic resection for metastatic renal cell carcinoma: a single center experience and review of the literature. Anticancer Res 28(1B): 361-365.